BioSLR latest issue

Now that 2007 is almost upon us, Volume 8 issue 3 2005/2006 of the Bio-Science Law Review has just been released. Published by Lawtext Publishing, this excellent journal continues to fascinate and infuriate its loyal readers to an extent that almost guarantees it cult status. This time round, the BioSLR has six articles, but it's still woefully thin. However, this waiflike supermodel on the IP publishing scene is always worth a read (or two).

Right: Oncomouse (Scott Draves)

This issue carries an obituary for the Oncomouse (by Andrew Sharples and Duncan Curley (McDermott Will & Emery's London office), a thoughtful piece on whether German utility model protection is available for biotechnological inventions (by a three-man team from Grund, Munich) and an interesting feature on German businesses reverse-merging into US companies as a means of accessing US capital markets (by a three-man team from Hogan & Hartson's Brussels and London offices).

Get your sample issue here
LATEST BIO-SLR LATEST BIO-SLR Reviewed by Jeremy on Sunday, December 10, 2006 Rating: 5

No comments:

All comments must be moderated by a member of the IPKat team before they appear on the blog. Comments will not be allowed if the contravene the IPKat policy that readers' comments should not be obscene or defamatory; they should not consist of ad hominem attacks on members of the blog team or other comment-posters and they should make a constructive contribution to the discussion of the post on which they purport to comment.

It is also the IPKat policy that comments should not be made completely anonymously, and users should use a consistent name or pseudonym (which should not itself be defamatory or obscene, or that of another real person), either in the "identity" field, or at the beginning of the comment. Current practice is to, however, allow a limited number of comments that contravene this policy, provided that the comment has a high degree of relevance and the comment chain does not become too difficult to follow.

Learn more here:

Powered by Blogger.